tirzepatide clinical trial versus Semaglutide Once Weekly in Patients with Type 2 Diabetes tirzepatide surpass 2 Reduction of
Description
This type of therapy helps a person to first understand the factors leading them to engage in binge eating, and then to learn and practice skills to help them get out of the binge eating cycle
Semaglutide mimics GLP-1 activity
In appropriate patients, medically supervised GLP-1 therapy has been associated with: Sustained weight reduction over time Improvements in A1C and overall blood sugar in people with type 2 diabetes Reduced waist circumference and visceral fat Better blood pressure, cholesterol, and other metabolic markers In some studies with Wegovy, a reduced risk of certain serious cardiovascular events in adults with obesity and existing heart disease At NuIQ, the goal of our GLP-1 semaglutide program is not just fast weight lossits sustainable weight management, better energy, and long-term metabolic health, all under the guidance of licensed medical professionals
It may be a good idea to monitor your blood sugar
Semaglutide and tirzepatide commonly cause gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort
That's that seems to make sense
